The primary focus of IDO1 inhibitor activity was to locally restore tryptophan availability to create a permissive environment for anti-tumor T cell proliferation and function, which we now know is only one regulatory pathway activated by regulated tryptophan metabolism. Here, IDO1 is linked to neoplasm.